Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04246047. IPD Sharing: NO. Countries: 20. Publications: 4.
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01351623. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01484275. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT00114101. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
ClinicalTrials.gov study NCT03319667. IPD Sharing: YES. Countries: 21. Publications: 3.
Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
ClinicalTrials.gov study NCT02331368. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
ClinicalTrials.gov study NCT02412228. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01217957. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
ClinicalTrials.gov study NCT00522392. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01096342. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
ClinicalTrials.gov study NCT00908232. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
ClinicalTrials.gov study NCT01556438. IPD Sharing: Not stated. Countries: 1. Publications: 1.
UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00569868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04113018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
ClinicalTrials.gov study NCT02104427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02136134. IPD Sharing: Not stated. Countries: 15. Publications: 9.
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00566098. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01478048. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
ClinicalTrials.gov study NCT01502085. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT00112723. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.